HIGHLIGHTS
- who: PD- and collaborators from the Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China have published the article: Machine Learning for Predicting Hyperglycemic Cases Induced by PD-1/PD-L1 Inhibitors, in the Journal: Journal of Healthcare Engineering of 19/08/2022
- what: From post-marketing monitoring the authors aimed to construct a machine learning algorithm to efficiently and rapidly predict hyperglycemic adverse reaction in patients using PD-1/L1 Methods. SVM is usually used as control algorithm in diabetic prediction , while the model has obtained the optimal parameters effectively considering . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.